Literature DB >> 6206738

Yellow fever monoclonal antibodies: type-specific and cross-reactive determinants identified by immunofluorescence.

T P Monath, J J Schlesinger, M W Brandriss, C B Cropp, W C Prange.   

Abstract

Monoclonal antibodies directed against the envelope glycoprotein and the NV3 non-structural viral protein of yellow fever (YF) were tested by the indirect fluorescent antibody technique against a variety of YF virus strains and heterologous flaviviruses. Monoclonal antibodies directed against the envelope glycoprotein exhibited YF strain-specificity, YF type-specificity, broad group cross-reactivity, or limited subgroup reactivity (YF + Banzi or YF + Koutango + Zika + Usutu + Uganda S). Monoclonal antibodies directed against NV3 reacted either with YF + Koutango or with YF + Banzi. These findings generally correlated with the results of biological tests reported previously. Monoclonal antibodies that were type-specific to YF will be useful for the rapid specific identification of YF virus isolates and are available from the Centers for Disease Control on request.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206738     DOI: 10.4269/ajtmh.1984.33.695

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  5 in total

1.  NS1 protein secretion during the acute phase of West Nile virus infection.

Authors:  Joanne Macdonald; Jessica Tonry; Roy A Hall; Brent Williams; Gustavo Palacios; Mundrigi S Ashok; Omar Jabado; David Clark; Robert B Tesh; Thomas Briese; W Ian Lipkin
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

2.  Sensitive and specific monoclonal immunoassay for detecting yellow fever virus in laboratory and clinical specimens.

Authors:  T P Monath; L J Hill; N V Brown; C B Cropp; J J Schlesinger; J F Saluzzo; J R Wands
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

3.  Serosurveillance of viral pathogens circulating in West Africa.

Authors:  Aileen E O'Hearn; Matthew A Voorhees; David P Fetterer; Nadia Wauquier; Moinya R Coomber; James Bangura; Joseph N Fair; Jean-Paul Gonzalez; Randal J Schoepp
Journal:  Virol J       Date:  2016-10-03       Impact factor: 4.099

4.  Mapping of a region of dengue virus type-2 glycoprotein required for binding by a neutralizing monoclonal antibody.

Authors:  T Trirawatanapong; B Chandran; R Putnak; R Padmanabhan
Journal:  Gene       Date:  1992-07-15       Impact factor: 3.688

5.  Mapping and Validation of Peptides Differentially Recognized by Antibodies from the Serum of Yellow Fever Virus-Infected or 17DD-Vaccinated Patients.

Authors:  Eneida Santos Oliveira; Naiara Clemente Tavares; Stella Garcia Colombarolli; Izabella Cristina Andrade Batista; Camila Sales Nascimento; Philip Louis Felgner; Rafael Ramiro de Assis; Carlos Eduardo Calzavara-Silva
Journal:  Viruses       Date:  2022-07-27       Impact factor: 5.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.